jasmina mallet
jasmina mallet
Affiliation inconnue
Adresse e-mail validée de aphp.fr
Titre
Citée par
Citée par
Année
Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset
E Bulzacka, L Boyer, F Schürhoff, O Godin, F Berna, L Brunel, ...
Schizophrenia bulletin 42 (5), 1290-1302, 2016
672016
Addictions in the COVID-19 era: current evidence, future perspectives a comprehensive review
J Mallet, C Dubertret, Y Le Strat
Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, 110070, 2021
512021
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort
M Andrianarisoa, L Boyer, O Godin, L Brunel, E Bulzacka, B Aouizerate, ...
Schizophrenia research 185, 173-181, 2017
462017
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
F Berna, D Misdrahi, L Boyer, B Aouizerate, L Brunel, D Capdevielle, ...
Schizophrenia research 169 (1-3), 255-261, 2015
342015
Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort
J Mallet, Y Le Strat, F Schürhoff, N Mazer, C Portalier, M Andrianarisoa, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 79, 332-339, 2017
282017
Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset
G Fond, L Boyer, M Boucekine, LA Aden, F Schürhoff, A Tessier, ...
Schizophrenia research 182, 84-89, 2017
282017
Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia
I Nkam, N Ramoz, F Breton, J Mallet, P Gorwood, C Dubertret
PLoS One 12 (1), e0170147, 2017
272017
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort
G Fond, O Godin, L Boyer, F Berna, M Andrianarisoa, N Coulon, L Brunel, ...
European archives of psychiatry and clinical neuroscience 269 (8), 985-992, 2019
252019
Anxiety, depression, trauma-related, and sleep disorders among healthcare workers duirng the COVID-19 pandemic: a systematic review and meta-analysis
M Marvaldi, J Mallet, C Dubertret, MR Moro, SB Guessoum
Neuroscience & Biobehavioral Reviews, 2021
232021
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort
G Fond, L Boyer, F Berna, O Godin, E Bulzacka, M Andrianarisoa, ...
The British Journal of Psychiatry 213 (2), 464-470, 2018
232018
A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders
SB Guessoum, Y Le Strat, C Dubertret, J Mallet
Progress in Neuro-Psychopharmacology and Biological Psychiatry 99, 109862, 2020
222020
Latent toxoplasma infection in real-world schizophrenia: results from the national FACE-SZ cohort
G Fond, L Boyer, F Schürhoff, F Berna, O Godin, E Bulzacka, ...
Schizophrenia research 201, 373-380, 2018
222018
Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort
G Fond, L Boyer, M Andrianarisoa, O Godin, E Bulzacka, F Berna, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 85, 62-68, 2018
192018
Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set
G Fond, F Berna, L Boyer, O Godin, L Brunel, M Andrianarisoa, ...
European archives of psychiatry and clinical neuroscience 268 (1), 17-26, 2018
192018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort
G Fond, E Bulzacka, M Boucekine, F Schürhoff, F Berna, O Godin, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, 8-18, 2019
182019
Metabolic syndrome and illness severity predict relapse at 1-year follow-up in schizophrenia: the FACE-SZ cohort
O Godin, M Leboyer, F Schürhoff, PM Llorca, L Boyer, M Andre, ...
The Journal of clinical psychiatry 79 (6), 0-0, 2018
182018
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
G Fond, N Resseguier, F Schürhoff, O Godin, M Andrianarisoa, L Brunel, ...
European archives of psychiatry and clinical neuroscience 268 (6), 541-553, 2018
182018
Factors associated with direct health care costs in schizophrenia: Results from the FACE-SZ French dataset
C Laidi, A Prigent, A Plas, M Leboyer, G Fond, K Chevreul, B Aouizerate, ...
European Neuropsychopharmacology 28 (1), 24-36, 2018
182018
Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
J Mallet, N Ramoz, Y Le Strat, P Gorwood, C Dubertret
European Archives of Psychiatry and Clinical Neuroscience 267 (7), 629-638, 2017
182017
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort
J Mallet, Y Le Strat, F Schürhoff, N Mazer, C Portalier, M Andrianarisoa, ...
European archives of psychiatry and clinical neuroscience 269 (4), 449-457, 2019
172019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20